ASND
Ascendis Pharma A/S · Healthcare · Market cap $14.8B(Price slightly stale)
Insiders sold $380K net in the last 90 days ·2 sellers, 1 buyer· latest Form 4 filed Sep 9, 2026
Insider Buying
$777K
reported purchases (SEC code P)
Insider Selling
$5.5M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Sep 9, 2026
Bodenhoff Mads
Ascendis Pharma A/S (ASND) has 8 SEC Form 4 filings (13 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Sep 9, 2026.
Inside the rolling window, 5 insiders at Ascendis Pharma A/S reported 5 open-market purchases totaling $777K and 3 open-market sales totaling $5.5M. The most active filer is Director BIENAIME JEAN JACQUES with 3 filings. Insiders have net sold $4.7M over the trailing 6 months. The most recent open-market filing is a sale of 3,000 shares by SVP & PAO Bodenhoff Mads, dated Sep 8, 2026, worth $811K.
- Industry:Biotechnology
- CEO:Jan Moller Mikkelsen
- Employees:1,189
- HQ:Hellerup, CR, DK
- IPO:2015-01-28
| Source | |||||||
|---|---|---|---|---|---|---|---|
Bodenhoff MadsFirst filing | SVP & PAO | Sale | 3,000 | $811K | Sep 9 | -8.4% | SEC ↗ |
HOLTUG LARSFirst filing | Director | Sale | 236 | $62K | Sep 3 | -11.9% | SEC ↗ |
| Director | Purchase | 2,000 | $493K | Aug 19 | -8.0% | SEC ↗ | |
| EVP & Chief Financial Officer | Purchase | 100 | $22K | Jun 2 | +10.3% | SEC ↗ | |
| Director | Purchase | 500 | $112K | Jun 1 | +9.2% | SEC ↗ | |
SMITH SCOTT THOMASFirst filing | EVP & Chief Financial Officer | Purchase | 250 | $56K | Jun 1 | +9.2% | SEC ↗ |
| Director | Purchase | 400 | $95K | May 27 | +1.5% | SEC ↗ | |
JENSEN FLEMMING STEENFirst filing | See Remarks | Sale | 19,460 | $4.6M | May 12 | — | SEC ↗ |
Congress trading ASND 1 all-time
- RRep. Gary James PalmerOther$1,001 - $15,0002018-10-05
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does ASND have?
Ascendis Pharma A/S (ASND) has 8 SEC Form 4 filings (13 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Sep 9, 2026.
When was the most recent SEC Form 4 filing for ASND?
The most recent Form 4 filing for ASND on Tracefour is dated Sep 9, 2026.
Who is the most active insider at ASND?
The most active SEC Form 4 filer at ASND in the rolling window is Director BIENAIME JEAN JACQUES, with 3 filings.
What is the net insider flow at ASND over the last 6 months?
Over the trailing 180 days, insiders at ASND have net sold $4.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ASND in the current window?
Inside the rolling window, insiders at ASND bought $777K and sold $5.5M based on SEC Form 4 filings.
Can I get alerts for ASND insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Ascendis Pharma A/S (ASND). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Ascendis Pharma A/S is in the Healthcare sector.